Novartis India lost 4.5% to Rs 450 at 09:45 IST on BSE after net profit declined 48.6% to Rs 13.87 crore on 1.7% rise in net sales to Rs 219.03 crore in Q1 June 2013 over Q1 June 2012.
The company announced Q1 result after market hours on Wednesday, 24 July 2013.
Meanwhile, the BSE Sensex was down 9.60 points, or 0.05%, to 20,081.08.
On BSE, 6,235 shares were traded in the counter as against an average daily volume of 19,890 shares in the past one quarter.
The stock hit 52-week low of Rs 448 in intraday trade today, 25 July 2013. The stock hit a high of Rs 460 so far during the day. The stock had hit a 52-week high of Rs 740.40 on 11 September 2012.
The stock had underperformed the market over the past one month till 24 July 2013, rising 0.12% compared with the Sensex's 8.36% gain. The scrip had also underperformed the market in past one quarter, sliding 19.45% as against Sensex's rise of 4.75%.
The small-cap company has an equity capital of Rs 15.98 crore. Face value per share is Rs 5.
Novartis India said that core business, pharmaceuticals recorded total income from operations of Rs 162.8 crore in Q1 June 2013 from Rs 162 crore in Q1 June 2012. The generics business registered total income from operations of Rs 15 crore in Q1 June 2013 from Rs 15.7 crore in Q1 June 2012. The animal health business registered total income from operations of Rs 25.6 crore in Q1 June 2013 from Rs 21.9 crore in Q1 June 2012. The OTC business recorded total income from operations of Rs 19.9 crore in Q1 June 2013 from Rs 19.9 crore in Q1 June 2012.
Novartis India said financial results for Q1 June 2013 were adversely impacted by significant rupee depreciation and slowdown in sales due to reduction in trade stocks after notification of the new drug price control order in May 2013. The expanded scope of drug price control is likely to have a significant impact on both revenue and profitability of the company. Necessary steps are being taken to reduce the adverse impact, the company said.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
